Trial Profile
A Two Stage Phase II Randomized Bilateral Comparison of Topical Targretin Gel 1% in Alopecia Areata.
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Bexarotene (Primary)
- Indications Alopecia areata
- Focus Adverse reactions; Therapeutic Use
- 31 Oct 2009 New trial record